Polar Pharma India Financials

BSE: 523333

₹0.82

₹-0.04 (-4.65%)

As on 17-Sep-2013IST

Market cap

₹1 Cr

Revenue (TTM)

₹16 Cr

P/E Ratio

--

P/B Ratio

-0

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Operating Revenue	--	16.20	10.91	0.03	0.26	25.85
Total Income	--	16.41	11.06	0.14	2.15	26.71
Total Expenditure	11.64	18.23	8.99	2.11	11.24	26.10
EBITDA	-2.15	-2.03	1.92	-2.08	-10.98	-0.25
Depreciation	2.25	2.25	2.23	2.28	2.33	2.40
EBIT	-4.40	-4.28	-0.31	-4.36	-13.31	-2.65
Interest	16.05	14.85	13.33	11.85	3.87	5.24
Other Income	--	0.21	0.15	0.12	1.89	0.86
Exceptional Items	--	0.02	-0.04	--	-44.00	--
Profit before Tax	-20.37	-18.90	-13.53	-16.10	-59.29	-7.04
Provision for Tax	--	--	--	--	8.64	-4.47
Profit after Tax	-20.37	-18.90	-13.53	-16.10	-67.93	-2.57

Liabilities (₹ Cr)	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Shareholder's Funds	-125.91	-114.22	-95.32	-81.79	-65.69	2.24
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.08	0.08	0.07	102.99	84.68	33.08
Current Liabilities	146.90	137.96	126.17	7.58	13.20	9.50
Total Liabilities	21.07	23.82	30.92	28.78	32.18	53.41

Assets (₹ Cr)	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Non-Current Assets	18.63	19.73	22.46	23.81	26.14	28.86
Current Assets	2.44	4.09	8.46	4.98	6.04	15.95
Total Assets	21.07	23.82	30.92	28.78	32.18	53.41
Total Debt*	--	132.18	117.18	102.99	84.68	41.68
Net Current Assets	-144.46	-133.87	-117.72	-2.61	-7.16	6.45
Contingent Liabilities	--	1.25	2.11	1.17	1.04	1.08

Cashflow (₹ Cr)	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Cash From Operating Activities	--	0.68	-0.92	2.39	-40.49	6.12
Cash Flow from Investing Activities	--	0.05	-0.05	0.01	0.38	0.62
Cash from Financing Activities	--	0.18	0.98	-2.42	39.14	-5.78
Net Cash Inflow / Outflow	--	0.92	0.02	-0.02	-0.98	0.96

Financials Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Adjusted EPS (₹)	-16.60	-15.40	-11.03	-13.12	-55.36	-2.09
Cash EPS (₹)	--	-13.56	-9.21	-11.26	-53.46	-0.13
Adjusted Book Value (₹)	--	-94.10	-78.70	-67.67	-54.56	0.80
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.55	-0.75	1.95	-33.00	4.99
Free Cash Flow per Share (₹)	--	-12.51	-11.46	-8.05	-42.30	5.07

Profitability Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
ROCE (%)	--	-20.34	-0.94	-21.14	-176.22	-3.84
ROE (%)	--	--	--	--	--	-113.60
ROA (%)	-84.89	-69.05	-45.33	-52.80	-176.47	-5.02
EBIT Margin (%)	--	-26.41	-2.83	-15,956.19	-5,175.76	-10.26
Net Margin (%)	--	-115.14	-122.35	-11,278.09	-3,163.24	-9.61
Cash Profit Margin (%)	--	-102.73	-103.57	--	--	-0.62

Growth Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Revenue Growth (%)	--	48.48	--	-89.37	-99.01	37.03
EBIT Growth (%)	-335.68	-1,284.47	92.92	67.22	-401.92	62.50
Net Profit Growth (%)	-35.27	-39.66	15.93	76.31	-2,547.98	71.64
EPS Growth (%)	-35.27	-39.66	15.93	76.31	-2,547.98	71.64
Book Value Growth (%)	--	-19.57	-16.30	-24.04	-6,888.08	-72.06

Valuation Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Price / Earnings	--	--	--	--	--	--
Price / Book Value	-0.01	-0.02	-0.03	-0.04	-0.04	8.22
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-64.09	-74.16	58.52	-54.48	-9.73	81.01
Close Price (₹)	2.35	2.06	2.54	2.85	2.41	6.61
High Price (₹)	3.20	5.30	5.37	4.80	7.99	18.00
Low Price (₹)	1.88	2.00	2.18	2.29	2.05	5.61
Market Cap (₹ Cr)	1.01	2.53	3.12	3.50	2.96	8.11

Solvency Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Debt to Equity	--	-1.16	-1.23	-1.26	-1.29	18.64
Short term debt to equity ratio	-1.16	-1.16	-1.23	--	--	--
Current Ratio	0.02	0.03	0.07	0.66	0.46	1.68
Quick Ratio	0.01	0.02	0.04	0.61	0.41	1.31
Interest Coverage	-0.27	-0.27	-0.02	-0.36	-14.30	-0.34

Operating Efficiency Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Debtors to sales (%)	--	0.98	16.06	96.14	10.22	24.66
Asset Turnover	--	0.59	0.37	0.00	0.01	0.51
Receivable days	--	21.53	29.75	350.91	4,544.30	114.46
Inventory Days	--	56.26	66.50	7,634.12	2,963.88	114.35
Payable days	--	106.76	290.69	--	136.34	27.38
Cash Conversion Cycle	--	-28.96	-194.44	7,985.02	7,371.84	201.43

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.